Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-14

Clinical Trial Update: The Peregrine Study: A Safety and Performance Study of Renal Denervation [NA]

View source ↗

Summary

The Peregrine Study, conducted by Ablative Solutions, Inc., completed its safety and performance evaluation of a renal denervation system for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peregrine Renal Denervation System

Snippet

Sponsor: Ablative Solutions, Inc. | Conditions: Hypertension | NA | Status: COMPLETED